SS
SEEL

Simplicity Solutions’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Simplicity Solutions’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3
Closed -$6.91K – 1259
2023
Q1 		$6.91K Buy
+3
New +$8.78K ﹤0.01% 1167

Other funds holding SEEL

GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Simplicity Solutions's SEEL Position: Q2 2023 in Review

Simplicity Solutions sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2023, closing a stake of 3 shares — an estimated $6.91K sold.

Simplicity Solutions first reported a position in SEEL in Q1 2023 and held it in 1 quarter. The position peaked at $6.91K in Q1 2023. 68 funds tracked by Wall St. Rank hold SEEL as of Q2 2023.

  • Simplicity Solutions reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplicity Solutions sold 3 Seelos Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $6.91K.
  • Simplicity Solutions first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Simplicity Solutions's Seelos Therapeutics, Inc. Common Stock position peaked at $6.91K in Q1 2023.
  • 68 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Simplicity Solutions's 13F filing for Q2 2023, filed 26 Jul 2023.